Rejuvenate Bio
PrivateLast Round
Financing
Jun 8, 2026
Total Funding Raised
$14M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Rejuvenate Bio is a biotechnology company that develops a biotechnology platform designed to increase healthspan and extend lifespan through novel gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuvenate Bio Comparables
Compare Rejuvenate Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genflow Biosciences | 84% | |
| Turn Biotechnologies | 80% | |
| Life Biosciences | 79% |
Rejuvenate Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Jun 8, 2026 | ||||
| Crowdfunding | Apr 27, 2026 | ||||
| Grant | Jul 1, 2024 | ||||
| Series A | Apr 19, 2021 |
Rejuvenate Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Financing, Series A |
| Connecticut Innovations | Financing |
| Digitalis Ventures | Financing, Series A |
| California Institute for Regenerative Medicine | Grant |
| KdT Ventures | Series A |
| VCapital | Series A, Financing |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 20% QoQ, from 15 to 18 employees.
- Aug 1, 2026
Open roles increased to 33, 3.5x the trailing average.
Recent news
Latest coverage and updates
- partners_withJun 24, 2026
Rejuvenate Bio, Inc. partners with Merck Group.
- partners_withJun 17, 2026
Rejuvenate Bio, Inc. partnered with Merck Animal Health USA on Jun 17th '26.
Rejuvenate Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rejuvenate Bio's valuation, stock price, and market status.
Is Rejuvenate Bio a public or private company?
Rejuvenate Bio is a private company.
What is the current stock price of Rejuvenate Bio?
Rejuvenate Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Rejuvenate Bio worth (valuation)?
Valuation information for Rejuvenate Bio is not publicly available.
Can I buy Rejuvenate Bio stock?
Rejuvenate Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rejuvenate Bio's last funding round?
Rejuvenate Bio's most recent funding round was Financing on June 8, 2026.
Who are the main investors in Rejuvenate Bio?
Key investors in Rejuvenate Bio include Kendall Capital Partners, VCapital.
Will Rejuvenate Bio IPO soon?
No public IPO plans have been announced for Rejuvenate Bio.
How can I track Rejuvenate Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rejuvenate Bio's secondary market activity and sign up for updates.